血管活性药物泵对泵更换技术的应用研究  

Application of Pump on Pump Replacement Technology for Vasoactive Drug

作　　者：孙党红[1] 葛支忱[1] 孙丽[1] 戴莉[1] 孟洁 朱玲[1] 许婷婷[1] 程铖[1] 

机构地区：[1]江苏省苏北人民医院心血管科,江苏扬州225001

出　　处：《中国卫生标准管理》2017年第27期69-71,共3页China Health Standard Management

基　　金：2014年度院级科研基金项目(YZUCMS201438)

摘　　要：目的探讨泵对泵更换技术的建立对于住院患者血管活性药物的临床治疗的影响。方法选取本院2014年1月—2015年12月收治的240例心脏病患者进行前瞻性分析,包括120例传统更换组以及120例泵对泵更换组,观察、比较传统更换技术和泵对泵更换技术维持使用血管活性药物患者血流动力学、心律失常等的影响。结果传统更换技术对于血压及心脏电生理具有显著的影响,收缩压及舒张压均明显波动(P<0.05),心律失常发生次数均明显上升(P<0.05);泵对泵更换技术更换后的收缩压及舒张压波动程度较小(P<0.05),未见心律失常发生次数上升(P>0.05)。结论泵对泵更换血管活性药物对维持药物持续泵入以及保证血流动力学稳定起到了重要作用,可以减少血压波动,并降低心律失常事件的发生率。Objective To explore the clinical effects of pump-to- pump replacement technology on hospitalized patients using vasoactive drugs. Methods 240 cases of patients with heart disease were selected to conduct prospective analysis in our cardiovascular department, from January 2014 to December 2015, including 120 cases of traditional replacement group and 120 cases of pump-to-pump replacement group. We observed and compared the hemodynamic changes and frequency of arrhythmia between traditional replacement group and pump-to-pump replacement group. Results Traditional replacement technology had significant influence on blood pressure and heart electrophysiology, which caused obvious fluctuations of systolic and diastolic blood pressure （P 〈 0.05）, and more arrhythmia （P 〈 0.05）; while pump-to- pump technology had lower level fluctuations of systolic and diastolic blood pressure （P 〈 0.05） and less arrhythmia （P 〉 0.05）. Conclusion Pump- to- pump replacement technology can maintain continuous drug pumping and guarantee hemodynamic stability, which plays an important role in reducing fluctuations of blood pressure and incidence of arrhythmia.

关 键 词：血管活性药物 泵 更换方法 心脏病 

分 类 号：R472[医药卫生—护理学]